AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

1.685

+0.0654.01%

Volume:191.76K

Turnover:316.48K

Market Cap:539.75M

PE:-8.12

High:1.705

Open:1.685

Low:1.605

Close:1.620

Loading ...

Overview Company News Filings

Imricor Medical Systems Says Hungary Hospital Performs First Atrial Ablations

MT Newswires Live

Imricor Commences VISABL-VT Trial

Imricor Medical Systems Says Consumables Revenue up 385% Year-Over-Year in March Quarter, Shares Rise 5%

MT Newswires Live

BUZZ-Australia's Imricor rises as Q1 revenue sees near fourfold jump

Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today

Imricor Receives CE Mark Approval for Electrophysiology Recording, Cardiac Simulator System; Shares Fall 4%

MT Newswires Live

Why Antipa, Imricor, Lynas, and Newmont shares are pushing higher today

Imricor Medical Systems Starts Clinical Trial at Amsterdam Medical Center

MT Newswires Live

BRIEF-Imricor Medical Systems To Raise A$70.0 Mln

Imricor Medical Systems Inc - to Raise a$70.0 Mln at an Offer Price of a$1.41 per Share

THOMSON REUTERS

Imricor Medical Systems Inc-Proposed Issue of Securities - Imr

THOMSON REUTERS

BRIEF-Imricor Medical Systems Seeks Trading Halt

Imricor Medical Systems Files Second Premarket Approval Module With US FDA; Shares Down 3%

MT Newswires Live

Imricor Medical Systems Reports Full Year 2024 Earnings

Simply Wall St.

When Will Imricor Medical Systems, Inc. (ASX:IMR) Breakeven?

Simply Wall St.

Corrected-Imricor Medical Systems Inc - Net Loss for Year $29.7 Mln (Corrects Currency to USD)

THOMSON REUTERS

BUZZ-Australia's Imricor Medical Systems rises after annual loss narrows

BRIEF-Imricor Medical Systems Says Net Loss For Year A$29.7 Million

Imricor Medical Systems - FY Adjusted Net Loss a$15.6 Mln

THOMSON REUTERS

Imricor Medical Systems' Catheter Receives CE Mark Certification

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IMR.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.685,"timestamp":1746079920000,"preClose":1.62,"halted":0,"volume":191764,"delay":0,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":231395861,"shares":320325092,"eps":-0.20754188194770626,"marketStatus":"Not Yet Opened","change":0.065,"latestTime":"05-01 16:12:00 AEST","open":1.685,"high":1.705,"low":1.605,"amount":316479,"amplitude":0.061728,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.20754188194770626,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746144000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.62,"openAndCloseTimeList":[[1746057600000,1746079200000]],"volumeRatio":0.4403589669840023,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":231395861,"roa":"-68.06%","roe":"-274.56%","lyrEps":-0.207531,"volumeRatio":0.4403589669840023,"shares":320325092,"dividePrice":0,"high":1.705,"amplitude":0.061728,"preClose":1.62,"low":1.605,"week52Low":0.41,"pbRate":"-46.73","psRate":"359.33","week52High":1.71,"institutionHeld":0,"latestPrice":1.685,"eps":-0.20753148425317663,"divideRate":0,"volume":191764,"delay":0,"ttmEps":-0.20753148425317663,"open":1.685,"prevYearClose":1.36,"prevWeekClose":1.605,"prevMonthClose":1.62,"prevQuarterClose":1.38,"fiveDayClose":1.51,"twentyDayClose":1.38,"sixtyDayClose":1.305},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532014342","title":"Imricor Medical Systems Says Hungary Hospital Performs First Atrial Ablations","url":"https://stock-news.laohu8.com/highlight/detail?id=2532014342","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532014342?lang=en_us&edition=fundamental","pubTime":"2025-05-01 08:56","pubTimestamp":1746060977,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said Semmelweis University's Heart and Vascular Center in Hungary performed its first atrial flutter ablations guided by real-time magnetic resonance imaging, through the company's NorthStar 3D mapping system, according to a Thursday filing with the Australian bourse.The company aims for continued expansion and growth across Europe, including adding more sites to the VISABL-VT clinical trial, the filing said.Imricor Medical Systems shares rose past 2% in morning trade Thursday.Price : $1.66, Change: $+0.040, Percent Change: +2.47%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","IMR.AU","BK7508","BK7007"],"gpt_icon":0},{"id":"2529504436","title":"Imricor Commences VISABL-VT Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2529504436","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529504436?lang=en_us&edition=fundamental","pubTime":"2025-04-23 19:55","pubTimestamp":1745409300,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, April 23, 2025----Imricor Medical Systems, Inc.   is pleased to announce that it has commenced the VISABL-VT clinical trial by completing the first-in-human ventricular ablation guided by real-time MRI with the Company’s NorthStar Mapping System. The procedure was performed by the team at the Amsterdam University Medical Centre , ranked in 2025 by Newsweek as the best hospital in The Netherlands, and in the top 35 worldwide.The procedure marked several world firsts. It was the first ventricular ablation to be guided by real-time MRI, and it was the first left-sided ablation to be performed under real-time MRI guidance. The patient was treated for right-sided and left-sided premature ventricular complexes .Imricor’s Chair and CEO, Steve Wedan, commented, \"We formed Imricor in 2006 with the goal of delivering MRI-compatible catheters and systems that would enable real-time MRI guidance of complex ventricular and atrial ablation procedures, where the power of MRI has the pote","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imricor-commences-visabl-vt-trial-115500347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IMR.AU","BK4585","AUMC","BK7508","BK4168","BK4588","BK7007","VT","BK7503"],"gpt_icon":0},{"id":"2529086592","title":"Imricor Medical Systems Says Consumables Revenue up 385% Year-Over-Year in March Quarter, Shares Rise 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529086592","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529086592?lang=en_us&edition=fundamental","pubTime":"2025-04-23 09:50","pubTimestamp":1745373002,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  reported a total revenue of $132,000 for the March quarter, with its consumables revenue of $104,000 up 385% year-over-year, according to a Wednesday Australian bourse filing.The firm reported net cash inflows from financing activities of $43 million in the March quarter, comprising net proceeds from the completion of the placement. Meanwhile, its net cash outflows from operating activities came in at $4.6 million.It also established Imricor BV, a wholly-owned subsidiary in the Netherlands, during the quarter. It hired the first capital sales managers in the US in preparation for a US commercial launch.On April 10, the first-in-man ventricular ablation guided by real-time interventional cardiac magnetic resonance was performed at the Amsterdam University Medical Centre.Its shares rose 5% in recent trading on Wednesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU"],"gpt_icon":0},{"id":"2529591312","title":"BUZZ-Australia's Imricor rises as Q1 revenue sees near fourfold jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2529591312","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529591312?lang=en_us&edition=fundamental","pubTime":"2025-04-23 09:20","pubTimestamp":1745371209,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imricor rises as Q1 revenue sees near fourfold jump** Shares of Imricor IMR.AX rise 5.71% to A$1.48, their biggest intraday pct gain since April 11** The medical device developer says its consumables revenue in Q1 up 385% Y-O-Y at $104,000 ** Stock hits its highest level since April 16 ** Stock up 8.82% this year, including the day's move  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nL4N3R103U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU"],"gpt_icon":0},{"id":"2528573084","title":"Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today","url":"https://stock-news.laohu8.com/highlight/detail?id=2528573084","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528573084?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:04","pubTimestamp":1744862698,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. At the time of writing, the benchmark index is up 0.6% to 7,803.9 points. Four ASX shares that have failed to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/17/why-imricor-nanosonics-perpetual-and-tourism-holdings-shares-are-sinking-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["THL.AU","BK7126","BK7125","BK7062","BK7508","MDR.AU","BK7007","NAN.AU","BK7094","PPT.AU","XJO.AU","IMR.AU","BK7503","BK7161"],"gpt_icon":0},{"id":"2528355757","title":"Imricor Receives CE Mark Approval for Electrophysiology Recording, Cardiac Simulator System; Shares Fall 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528355757","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528355757?lang=en_us&edition=fundamental","pubTime":"2025-04-17 10:51","pubTimestamp":1744858297,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said that its Advantage-MR electrophysiology recording and cardiac stimulator system received CE mark certification under the European Union's new medical device regulations regime, according to a Thursday Australian bourse filing.The commercial launch of its second-generation Vision-MR ablation catheter and the new Advantage-MR system is planned to start in June across new and existing sites in the EU.In February, the company's second-generation Vision-MR ablation catheter received CE mark approval under the medical device regulations regime.Imricor's shares fell almost 4% in recent trading on Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK4585","CE","BK7508","BK7503","BK7007","BK4109","BK4588"],"gpt_icon":0},{"id":"2526500507","title":"Why Antipa, Imricor, Lynas, and Newmont shares are pushing higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2526500507","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526500507?lang=en_us&edition=fundamental","pubTime":"2025-04-11 13:30","pubTimestamp":1744349419,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index (ASX: XJO) has followed Wall Street's lead and dropped into the red. At the time of writing, the benchmark index is down 1.2% to 7,616.6 points. Four ASX share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/11/why-antipa-imricor-lynas-and-newmont-shares-are-pushing-higher-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LYC.AU","AUMC","IGO.AU","BK7104","BK4168","NEM.AU","BK7504","AZY.AU","IMR.AU","BK7007","BK7508","BK7503","BK7507","XJO.AU","BK7095","BK7506"],"gpt_icon":0},{"id":"2526521062","title":"Imricor Medical Systems Starts Clinical Trial at Amsterdam Medical Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2526521062","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526521062?lang=en_us&edition=fundamental","pubTime":"2025-04-11 08:13","pubTimestamp":1744330432,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  started the VISABL-VT clinical trial after performing the first-in-human ventricular ablation guided by real-time interventional cardiac magnetic resonance  at the Amsterdam University Medical Center, according to a Friday filing with the Australian bourse.The trial evaluates the safety and effectiveness of radiofrequency ablation of ventricular tachycardia in ischemic cardiomyopathy using the Vision-MR Ablation Catheter 2.0 in the iCMR environment.The patient was treated for both right-sided and left-sided premature ventricular complexes, the filing said.Ventricular ablation is a procedure used to treat ventricular tachycardia, a rapid, abnormal heartbeat.Price : $1.36, Change: $+0.18, Percent Change: +14.83%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7007","BK7508","BK7503"],"gpt_icon":0},{"id":"2520110201","title":"BRIEF-Imricor Medical Systems To Raise A$70.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2520110201","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520110201?lang=en_us&edition=fundamental","pubTime":"2025-03-20 08:52","pubTimestamp":1742431963,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems To Raise A$70.0 MlnMarch 20 (Reuters) - Imricor Medical Systems Inc IMR.AX:TO RAISE A$70.0 MILLION AT AN OFFER PRICE OF A$1.41 PER SHAREFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nFWN3Q218N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","BK7007","IMR.AU","BK7508"],"gpt_icon":0},{"id":"2520118357","title":"Imricor Medical Systems Inc -  to Raise a$70.0 Mln at an Offer Price of a$1.41 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2520118357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520118357?lang=en_us&edition=fundamental","pubTime":"2025-03-20 06:39","pubTimestamp":1742423963,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q218N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7007","BK7508","IMR.AU"],"gpt_icon":0},{"id":"2520118350","title":"Imricor Medical Systems Inc-Proposed Issue of Securities - Imr","url":"https://stock-news.laohu8.com/highlight/detail?id=2520118350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520118350?lang=en_us&edition=fundamental","pubTime":"2025-03-20 06:39","pubTimestamp":1742423946,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUE2ZKRXZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7508","BK7007","IMR.AU"],"gpt_icon":0},{"id":"2520944582","title":"BRIEF-Imricor Medical Systems Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2520944582","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520944582?lang=en_us&edition=fundamental","pubTime":"2025-03-17 06:50","pubTimestamp":1742165421,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Seeks Trading HaltMarch 17 (Reuters) - Imricor Medical Systems IMR.AX:IMRICOR MEDICAL SYSTEMS INC - SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL RAISINGFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250316:nFWN3PX1EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7007","IMR.AU","BK7503"],"gpt_icon":0},{"id":"2516553693","title":"Imricor Medical Systems Files Second Premarket Approval Module With US FDA; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516553693","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516553693?lang=en_us&edition=fundamental","pubTime":"2025-03-04 08:24","pubTimestamp":1741047884,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  submitted its second premarket approval module for US Food and Drug Administration  review, according to a Tuesday filing with the Australian bourse.The module covers design, manufacturing, and quality processes for seven products, and includes design controls, raw material receipt, inspection, storage, build procedures, process validation, part and device traceability, and quality management systems, the filing said.The company's NorthStar 3D mapping and guidance system will be submitted next under the 510 process.Shares fell nearly 3% in morning trade Tuesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","BK7007","BK7508","IMR.AU"],"gpt_icon":0},{"id":"2516621315","title":"Imricor Medical Systems Reports Full Year 2024 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2516621315","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516621315?lang=en_us&edition=fundamental","pubTime":"2025-03-02 06:59","pubTimestamp":1740869966,"startTime":"0","endTime":"0","summary":"ASX:IMR Earnings and Revenue History March 1st 2025. All figures shown in the chart above are for the trailing 12 month  period. Looking ahead, revenue is forecast to grow 88% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Medical Equipment industry in Australia.The company's share price is broadly unchanged from a week ago.Before we wrap up, we've discovered 3 warning signs for Imricor Medical Systems that you should be aware of.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imricor-medical-systems-reports-full-225926665.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IMR.AU"],"gpt_icon":0},{"id":"2516344307","title":"When Will Imricor Medical Systems, Inc. (ASX:IMR) Breakeven?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516344307","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516344307?lang=en_us&edition=fundamental","pubTime":"2025-03-01 05:44","pubTimestamp":1740779079,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse Imricor Medical Systems, Inc.'s  business as it appears the company may be on the cusp of a considerable accomplishment. Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging  compatible products for cardiac catheter ablation procedures in the United States. The AU$427m market-cap company posted a loss in its most recent financial year of US$23m and a latest trailing-twelve-month loss of US$20m shrinking the gap between loss and breakeven. The most pressing concern for investors is Imricor Medical Systems' path to profitability – when will it breakeven?Below we will provide a high-level summary of the industry analysts’ expectations for the company.View our latest analysis for Imricor Medical Systems. According to some industry analysts covering Imricor Medical Systems, breakeven is near. They anticipate the company to incur a final loss in 2026, before generating po","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imricor-medical-systems-inc-asx-214439083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7508","BK7007","BK7503","BK7057","MRI.AU","IMR.AU"],"gpt_icon":0},{"id":"2514447278","title":"Corrected-Imricor Medical Systems Inc - Net Loss for Year $29.7 Mln (Corrects Currency to USD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514447278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514447278?lang=en_us&edition=fundamental","pubTime":"2025-02-27 14:17","pubTimestamp":1740637037,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL5N3PI0DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7508","BK7503","IMR.AU"],"gpt_icon":0},{"id":"2514843629","title":"BUZZ-Australia's Imricor Medical Systems rises after annual loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2514843629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514843629?lang=en_us&edition=fundamental","pubTime":"2025-02-27 12:15","pubTimestamp":1740629738,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imricor Medical Systems rises after annual loss narrows** Shares of Imricor Medical Systems IMR.AX rise 4.5% to A$1.525** Stock rose as much as 7.2% to A$1.565 earlier in the day, its largest intraday pct gain since February 14** The medical device developer narrows FY24 adjusted net loss to $15.6 million vs $16.7 million last year** Also logs revenue $959,424 for fiscal 2024, up from $615,568 last year** Says revenue growth driven by capital sales and new site activations** More than 258,000 shares change hands vs 30-day avg volume of 236,000 shares** Stock up 13.2% YTD, including current session's moves  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI0AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7508","BK7503","BK7007"],"gpt_icon":0},{"id":"2514132498","title":"BRIEF-Imricor Medical Systems Says Net Loss For Year A$29.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514132498","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514132498?lang=en_us&edition=fundamental","pubTime":"2025-02-27 09:15","pubTimestamp":1740618958,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Says Net Loss For Year A$29.7 MillionFeb 27 (Reuters) - Imricor Medical Systems Inc IMR.AX:NET LOSS FOR YEAR A$29.7 MILLIONFY ADJUSTED NET LOSS A$15.6 MILLIONFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PH1SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7508","BK7503","BK7007"],"gpt_icon":0},{"id":"2514605358","title":"Imricor Medical Systems - FY Adjusted Net Loss a$15.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514605358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514605358?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:07","pubTimestamp":1740604059,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1SB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMR.AU","BK7007","BK7503"],"gpt_icon":0},{"id":"2512433491","title":"Imricor Medical Systems' Catheter Receives CE Mark Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=2512433491","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512433491?lang=en_us&edition=fundamental","pubTime":"2025-02-19 09:59","pubTimestamp":1739930373,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems (ASX:IMR) said that its second-generation vision-magnetic resonance ablation catheter to be used for the potential treatment of type 1 atrial flutter has received CE mark certi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK4585","BK7508","XJO.AU","BK7094","MDR.AU","A27.SI","BK4588","BK7007","Y3D.SI","XAO.AU","BK7503","BK4109","XKO.AU","CE","BK6057"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null},{"date":"2024-04-30","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714435200000,"name":null,"time":"","dateTimestamp":1714399200000,"actualEps":null},{"date":"2024-02-29","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709161200000,"name":null,"time":"","dateTimestamp":1709125200000,"actualEps":null},{"market":"AU","date":"2024-02-05","symbol":"IMR.AU","defaultRemindTime":1707087600000,"type":"split","dateTimestamp":1707051600000,"forFactor":968436,"toFactor":1000000,"ratio":0.968436}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[]}}